If a patient is under section 2 or 3, treatment can be administered even if they refuse it. Patients who are detained under section 3 can be treated against their will, regardless of their capacity. However, after three months, if the patient still refuses treatment, an impartial psychiatrist must review the proposed medication and agree with the treating team’s plan. The Mental Health Act takes precedence over the Mental Capacity Act, so a best interests meeting is not necessary. The treating team must consider the patient’s best interests, and in this case, they believe that medication is necessary for Rosie’s mental health. While benzodiazepines can alleviate agitation and distress, they are unlikely to improve her psychotic symptoms, so they are not a suitable option. If Rosie continues to refuse treatment after three months under section 3, a second opinion will be required.

Sectioning under the Mental Health Act is a legal process used for individuals who refuse voluntary admission. This process excludes patients who are under the influence of drugs or alcohol. There are several sections under the Mental Health Act that allow for different types of admission and treatment.

Section 2 allows for admission for assessment for up to 28 days, which is not renewable. An Approved Mental Health Professional (AMHP) or the nearest relative (NR) can make the application on the recommendation of two doctors, one of whom should be an approved consultant psychiatrist. Treatment can be given against the patient’s wishes.

Section 3 allows for admission for treatment for up to 6 months, which can be renewed. An AMHP and two doctors, both of whom must have seen the patient within the past 24 hours, can make the application. Treatment can also be given against the patient’s wishes.

Section 4 is used as an emergency 72-hour assessment order when a section 2 would involve an unacceptable delay. A GP and an AMHP or NR can make the application, which is often changed to a section 2 upon arrival at the hospital.

Section 5(2) allows a doctor to legally detain a voluntary patient in hospital for 72 hours, while section 5(4) allows a nurse to detain a voluntary patient for 6 hours.

Section 17a allows for Supervised Community Treatment (Community Treatment Order) and can be used to recall a patient to the hospital for treatment if they do not comply with the conditions of the order in the community, such as taking medication.

Section 135 allows for a court order to be obtained to allow the police to break into a property to remove a person to a Place of Safety. Section 136 allows for someone found in a public place who appears to have a mental disorder to be taken by the police to a Place of Safety. This section can only be used for up to 24 hours while a Mental Health Act assessment is arranged.

Schizophrenia is a mental disorder that can have varying prognoses depending on certain factors. Some indicators associated with a poor prognosis include a strong family history of the disorder, a gradual onset of symptoms, a low IQ, a prodromal phase of social withdrawal, and a lack of an obvious precipitant. These factors can contribute to a more severe and chronic course of the illness, making it more difficult to manage and treat. It is important for individuals with schizophrenia and their loved ones to be aware of these indicators and seek appropriate treatment and support.

Fluoxetine is the preferred SSRI for children and adolescents.

Selective serotonin reuptake inhibitors (SSRIs) are commonly used as the first-line treatment for depression. Citalopram and fluoxetine are the preferred SSRIs, while sertraline is recommended for patients who have had a myocardial infarction. However, caution should be exercised when prescribing SSRIs to children and adolescents. Gastrointestinal symptoms are the most common side-effect, and patients taking SSRIs are at an increased risk of gastrointestinal bleeding. Patients should also be aware of the possibility of increased anxiety and agitation after starting a SSRI. Fluoxetine and paroxetine have a higher propensity for drug interactions.

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a warning regarding the use of citalopram due to its association with dose-dependent QT interval prolongation. As a result, citalopram and escitalopram should not be used in patients with congenital long QT syndrome, known pre-existing QT interval prolongation, or in combination with other medicines that prolong the QT interval. The maximum daily dose of citalopram is now 40 mg for adults, 20 mg for patients older than 65 years, and 20 mg for those with hepatic impairment.

When initiating antidepressant therapy, patients should be reviewed by a doctor after 2 weeks. Patients under the age of 25 years or at an increased risk of suicide should be reviewed after 1 week. If a patient responds well to antidepressant therapy, they should continue treatment for at least 6 months after remission to reduce the risk of relapse. When stopping a SSRI, the dose should be gradually reduced over a 4 week period, except for fluoxetine. Paroxetine has a higher incidence of discontinuation symptoms, including mood changes, restlessness, difficulty sleeping, unsteadiness, sweating, gastrointestinal symptoms, and paraesthesia.

When considering the use of SSRIs during pregnancy, the benefits and risks should be weighed. Use during the first trimester may increase the risk of congenital heart defects, while use during the third trimester can result in persistent pulmonary hypertension of the newborn. Paroxetine has an increased risk of congenital malformations, particularly in the first trimester.

This scenario requires you to demonstrate your ability to evaluate and handle a patient who is contemplating suicide. The patient in question has several risk factors, including being male, having a history of depression, recently going through a separation, and expressing a desire to end his life in the future. It is crucial to respond appropriately in this situation. The most suitable team to evaluate and manage this patient is the CRISIS team, who can provide urgent assessment and care.

The other options are not as effective. Transferring the patient to the Emergency Department would only delay the referral to the crisis team. CAMH, which stands for child and adolescent mental health, is not the appropriate team to handle this case. It is not within your professional scope to initiate relationship counseling. Given the patient’s numerous risk factors, it would not be safe to discharge him without a psychiatric evaluation.

In 2022, NICE updated its guidelines on managing depression and now classifies it as either less severe or more severe based on a patient’s PHQ-9 score. For less severe depression, NICE recommends discussing treatment options with patients and considering the least intrusive and resource-intensive treatment first. Antidepressant medication should not be routinely offered as first-line treatment unless it is the patient’s preference. Treatment options for less severe depression include guided self-help, group cognitive behavioral therapy, group behavioral activation, individual CBT or BA, group exercise, group mindfulness and meditation, interpersonal psychotherapy, SSRIs, counseling, and short-term psychodynamic psychotherapy. For more severe depression, NICE recommends a shared decision-making approach and suggests a combination of individual CBT and an antidepressant as the preferred treatment option. Other treatment options for more severe depression include individual CBT or BA, antidepressant medication, individual problem-solving, counseling, short-term psychodynamic psychotherapy, interpersonal psychotherapy, guided self-help, and group exercise.

Selective serotonin reuptake inhibitors (SSRIs) are commonly used as the first-line treatment for depression. Citalopram and fluoxetine are the preferred SSRIs, while sertraline is recommended for patients who have had a myocardial infarction. However, caution should be exercised when prescribing SSRIs to children and adolescents. Gastrointestinal symptoms are the most common side-effect, and patients taking SSRIs are at an increased risk of gastrointestinal bleeding. Patients should also be aware of the possibility of increased anxiety and agitation after starting a SSRI. Fluoxetine and paroxetine have a higher propensity for drug interactions.

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a warning regarding the use of citalopram due to its association with dose-dependent QT interval prolongation. As a result, citalopram and escitalopram should not be used in patients with congenital long QT syndrome, known pre-existing QT interval prolongation, or in combination with other medicines that prolong the QT interval. The maximum daily dose of citalopram is now 40 mg for adults, 20 mg for patients older than 65 years, and 20 mg for those with hepatic impairment.

When initiating antidepressant therapy, patients should be reviewed by a doctor after 2 weeks. Patients under the age of 25 years or at an increased risk of suicide should be reviewed after 1 week. If a patient responds well to antidepressant therapy, they should continue treatment for at least 6 months after remission to reduce the risk of relapse. When stopping a SSRI, the dose should be gradually reduced over a 4 week period, except for fluoxetine. Paroxetine has a higher incidence of discontinuation symptoms, including mood changes, restlessness, difficulty sleeping, unsteadiness, sweating, gastrointestinal symptoms, and paraesthesia.

When considering the use of SSRIs during pregnancy, the benefits and risks should be weighed. Use during the first trimester may increase the risk of congenital heart defects, while use during the third trimester can result in persistent pulmonary hypertension of the newborn. Paroxetine has an increased risk of congenital malformations, particularly in the first trimester.

The young man in question is likely suffering from borderline personality disorder (BPD), also known as emotionally unstable personality disorder (EUPD). This condition is characterized by unstable relationships, alternating between idealization and devaluation of others, recurrent self-harm, unstable self-image and self-esteem, suicidal behavior, difficulty controlling anger, and efforts to avoid abandonment. All of these traits are present in this patient, making BPD the most likely diagnosis.

Narcissistic personality disorder is not a likely diagnosis for this patient, as it is characterized by a grandiose sense of self-importance, lack of empathy, and a sense of entitlement. These traits are not present in this patient, and his periods of devaluing her partner are temporary and not pervasive.

Dependent personality disorder is also an unlikely diagnosis, as this condition is characterized by a pervasive need for others to make decisions for the patient and constant reassurance. While the patient has felt that he cannot live without his partner in the past, his labile mood and alternating view of his partner make this diagnosis less likely.

Paranoid personality disorder is also an unlikely diagnosis, as patients with this condition tend to be reluctant to confide in others and have an unforgiving attitude when insulted or questioned. The patient in question does not exhibit these traits, and his difficulty with trusting friends is likely due to his belief that he is undeserving of them.

Personality disorders are a set of personality traits that are maladaptive and interfere with normal functioning in life. It is estimated that around 1 in 20 people have a personality disorder, which are typically categorized into three clusters: Cluster A, which includes Odd or Eccentric disorders such as Paranoid, Schizoid, and Schizotypal; Cluster B, which includes Dramatic, Emotional, or Erratic disorders such as Antisocial, Borderline (Emotionally Unstable), Histrionic, and Narcissistic; and Cluster C, which includes Anxious and Fearful disorders such as Obsessive-Compulsive, Avoidant, and Dependent.

Paranoid individuals exhibit hypersensitivity and an unforgiving attitude when insulted, a reluctance to confide in others, and a preoccupation with conspirational beliefs and hidden meanings. Schizoid individuals show indifference to praise and criticism, a preference for solitary activities, and emotional coldness. Schizotypal individuals exhibit odd beliefs and magical thinking, unusual perceptual disturbances, and inappropriate affect. Antisocial individuals fail to conform to social norms, deceive others, and exhibit impulsiveness, irritability, and aggressiveness. Borderline individuals exhibit unstable interpersonal relationships, impulsivity, and affective instability. Histrionic individuals exhibit inappropriate sexual seductiveness, a need to be the center of attention, and self-dramatization. Narcissistic individuals exhibit a grandiose sense of self-importance, lack of empathy, and excessive need for admiration. Obsessive-compulsive individuals are occupied with details, rules, and organization to the point of hampering completion of tasks. Avoidant individuals avoid interpersonal contact due to fears of criticism or rejection, while dependent individuals have difficulty making decisions without excessive reassurance from others.

Personality disorders are difficult to treat, but a number of approaches have been shown to help patients, including psychological therapies such as dialectical behavior therapy and treatment of any coexisting psychiatric conditions.

It is probable that the patient is experiencing conversion disorder, which is often triggered by stress and involves the loss of motor or sensory function. The potential grand final rugby game may have been the stressor in this case.

Somatisation disorder is unlikely as it requires the presence of multiple physical symptoms for at least two years, whereas this patient has only one acute onset symptom. Dissociative disorder is also improbable as there are no evident psychiatric symptoms such as amnesia, stupor, or fugue. The patient remembers clearly that he has a football game and has not sustained any recent injuries.

However, factitious disorder cannot be ruled out entirely. It is possible that the patient is feigning the symptom to avoid playing the game, but further investigation is necessary. The patient claims to be eager to return to playing, which does not support the notion of factitious disorder.

Psychiatric Terms for Unexplained Symptoms

There are various psychiatric terms used to describe patients who exhibit symptoms for which no organic cause can be found. One such disorder is somatisation disorder, which involves the presence of multiple physical symptoms for at least two years, and the patient’s refusal to accept reassurance or negative test results. Another disorder is illness anxiety disorder, which is characterized by a persistent belief in the presence of an underlying serious disease, such as cancer, despite negative test results.

Conversion disorder is another condition that involves the loss of motor or sensory function, and the patient does not consciously feign the symptoms or seek material gain. Patients with this disorder may be indifferent to their apparent disorder, a phenomenon known as la belle indifference. Dissociative disorder, on the other hand, involves the process of ‘separating off’ certain memories from normal consciousness, and may manifest as amnesia, fugue, or stupor. Dissociative identity disorder (DID) is the most severe form of dissociative disorder and was previously known as multiple personality disorder.

Factitious disorder, also known as Munchausen’s syndrome, involves the intentional production of physical or psychological symptoms. Finally, malingering is the fraudulent simulation or exaggeration of symptoms with the intention of financial or other gain. Understanding these psychiatric terms can help healthcare professionals better diagnose and treat patients with unexplained symptoms.

Differentiating between Mental Disorders: Tourette’s Syndrome, Malingering, Conduct Disorder, Dissocial Personality Disorder, and Schizophrenia

Tourette’s Syndrome is a tic disorder that usually develops in childhood or adolescence, characterized by multiple motor tics and one or more vocal tics. The vocal tics need not be complete words or phrases and are often throat-clearing and grunting. Anti-psychotics such as pimozide, risperidone, and sulpiride have been shown to be of benefit.

Malingering is the act of fabricating symptoms for some sort of secondary gain, such as financial, manipulative, avoidance of school, obtaining drugs, or gaining sympathy or attention.

Conduct Disorder is a mental disorder diagnosed before or after the age of 10, characterized by a persistent and repetitive pattern of behavior that violates either the basic rights of others or goes against age-developmental norms. Childhood onset disorder can be linked to attention deficit/hyperactivity disorder (ADHD) type symptoms.

Dissocial Personality Disorder is characterized by a long-term disregard for others or the violation of others. Its precursor is conduct disorder. Antisocial personality disorder can be diagnosed when the patient reaches the age of 18 and has a history of conduct disorder in childhood or adolescence.

Schizophrenia does not typically present with involuntary movements. There is also no history of hallucinations, auditory or visual, or confused thinking.

Trauma-focused cognitive behavioural therapy or EMDR are both effective methods for managing PTSD.

Understanding Post-Traumatic Stress Disorder (PTSD)

Post-traumatic stress disorder (PTSD) is a mental health condition that can develop in individuals of any age following a traumatic event. This can include experiences such as natural disasters, accidents, or even childhood abuse. PTSD is characterized by a range of symptoms, including re-experiencing the traumatic event through flashbacks or nightmares, avoidance of situations or people associated with the event, hyperarousal, emotional numbing, depression, and even substance abuse.

Effective management of PTSD involves a range of interventions, depending on the severity of the symptoms. Single-session interventions are not recommended, and watchful waiting may be used for mild symptoms lasting less than four weeks. Military personnel have access to treatment provided by the armed forces, while trauma-focused cognitive behavioral therapy (CBT) or eye movement desensitization and reprocessing (EMDR) therapy may be used in more severe cases.

It is important to note that drug treatments for PTSD should not be used as a routine first-line treatment for adults. If drug treatment is used, venlafaxine or a selective serotonin reuptake inhibitor (SSRI), such as sertraline, should be tried. In severe cases, NICE recommends that risperidone may be used. Overall, understanding the symptoms and effective management of PTSD is crucial in supporting individuals who have experienced traumatic events.

Strategies for Preventing Alcohol Relapse

For individuals with alcohol-use disorders, preventing relapse is crucial for maintaining sobriety. Here are some strategies that can help:

1. Join a local Alcoholics Anonymous group or other self-help groups that require total abstinence. Active participation in these groups can offer the best chance of preventing relapses.

2. Limit consumption to socially appropriate amounts. Even small amounts of alcohol can trigger a relapse, so individuals who have completed a detoxification program are encouraged not to drink at all.

3. Take disulfiram as prescribed. This medication can cause unpleasant symptoms when alcohol is consumed, making it a deterrent for those who struggle with alcohol use. However, it should only be taken in the context of an appropriate alcohol detoxification program.

4. Take naltrexone as prescribed. This medication can help reduce cravings for alcohol, but it should not be taken as a deterrent before attending a party.

5. Plan a definite number of drinks before attending a party. However, individuals who have completed a detoxification program are still encouraged not to drink at all to prevent relapse.

By implementing these strategies, individuals with alcohol-use disorders can increase their chances of maintaining sobriety and preventing relapse.

Common Psychiatric Medications and Their Side-Effects

Haloperidol: A typical antipsychotic drug that can cause extrapyramidal side-effects (EPSEs), including acute dystonic reactions. Treatment is with anticholinergic drugs or benzodiazepines.

Clozapine: An atypical antipsychotic mainly used in treatment-resistant schizophrenia. Common side-effects include sedation, constipation, hypersalivation, weight gain, and metabolic syndrome. Rare but important side-effects include agranulocytosis, arrhythmias, and myocarditis. EPSEs are possible but rare.

Diazepam: A benzodiazepine used in anxiety, insomnia, seizures, and muscle spasms. Side-effects include sedation, muscle weakness, drowsiness, and confusion. EPSEs are not a recognised side-effect and may improve with the use of benzodiazepines.

Lithium: A mood stabiliser used in the treatment of mania, depression, and bipolar disorder. Side-effects include gastrointestinal disturbances, tremor, polydipsia, polyuria, and electrolyte disturbances. Lithium-induced hypothyroidism is common. EPSEs are not a side-effect of lithium.

Olanzapine: An atypical antipsychotic used in the treatment of schizophrenia and acute mania. Common side-effects include sedation, weight gain, and metabolic symptoms. EPSEs can occur but are not a typical side-effect of olanzapine.

Common Mental Health Disorders: Symptoms and Characteristics

Bulimia Nervosa
Bulimia nervosa is an eating disorder characterized by binge eating followed by purging, usually in the form of vomiting. Patients with bulimia nervosa tend to have normal BMI despite purging behavior. Symptoms include teeth erosion, swelling along the mandibular rami (parotitis), and excoriations of the knuckles (Russell’s sign).

Gender Dysphoria
Gender dysphoria is a condition where an individual experiences a strong identification with a gender other than that assigned at birth. This can be managed through social or medical transition, such as hormone or surgical treatments that are gender-affirming.

Anorexia Nervosa
Anorexia nervosa is characterized by decreased dietary intake with or without purging behavior. Patients with anorexia nervosa tend to have extremely low BMI due to low calorie intake. Symptoms include early osteoporosis and electrolyte abnormalities due to malnutrition.

Avoidant Personality Disorder
Avoidant personality disorder is characterized by a person who wishes to have friends and social outlets but is so shy that they are unable to form relationships out of fear of rejection. This is different from the schizoid personality, which prefers to be alone.

Binge Eating Disorder
Binge eating disorder is characterized by purely binge eating without purging behavior. Symptoms include distress and weight gain.

Understanding Personality Disorders: Emotionally Unstable Personality Disorder

Personality disorders are complex and severe disturbances in an individual’s character and behavior, often leading to personal and social disruption. These disorders are challenging to treat, but psychological and pharmacological interventions can help manage symptoms. One of the most common types of personality disorder is borderline personality disorder, characterized by intense emotions, unstable relationships, impulsive behavior, and anxieties about abandonment. Schizoid personality disorder, avoidant personality disorder, dependent personality disorder, and narcissistic personality disorder are other types of personality disorders, each with their own unique symptoms. However, the patient in this scenario is most consistent with borderline personality disorder. Understanding personality disorders is crucial in providing appropriate treatment and support for individuals struggling with these conditions.

Understanding Movement Disorders Associated with Anti-Psychotic Medication

Anti-psychotic medication can cause a range of movement disorders, including tardive dyskinesia, akathisia, and Parkinsonism. Tardive dyskinesia is a common side-effect of long-term treatment with anti-psychotics, but can also occur with minimal doses. It is characterized by choreoathetoid movements, often starting in the fingers and tongue and becoming more generalized. Treatment is often unsuccessful, but may involve switching to a different medication or using agents such as tetrabenazine or benzodiazepines. Akathisia is an inner feeling of motor restlessness, with voluntary movements such as pacing or rocking. Parkinsonism is characterized by resting tremor, rigidity, and bradykinesia. These movement disorders can be mistaken for other conditions such as Huntington’s or Wilson’s disease, but the association with anti-psychotic medication and the specific symptoms make tardive dyskinesia a more likely option. It is important for healthcare professionals to monitor patients on anti-psychotic medication for these potential side-effects and adjust treatment as necessary.

Completed suicide can be prevented by certain protective factors such as having social support, religious beliefs, having children at home, and regretting a previous attempt. It is important to note that the duration of mental illness is not a determining factor, but having a mental illness, especially depression, increases the risk. Alcohol misuse is also a risk factor, but in this scenario, the fact that the person does not drink much alcohol is not particularly protective. The individual in the scenario lacks social support and is not religious, making those options incorrect. However, having children present at home is a protective factor.

Suicide Risk Factors and Protective Factors

Suicide risk assessment is a common practice in psychiatric care, with patients being stratified into high, medium, or low risk categories. However, there is a lack of evidence on the positive predictive value of individual risk factors. A review in the BMJ concluded that such assessments may not be useful in guiding decision-making, as 50% of suicides occur in patients deemed low risk. Nevertheless, certain factors have been associated with an increased risk of suicide, including male sex, history of deliberate self-harm, alcohol or drug misuse, mental illness, depression, schizophrenia, chronic disease, advancing age, unemployment or social isolation, and being unmarried, divorced, or widowed.

If a patient has attempted suicide, there are additional risk factors to consider, such as efforts to avoid discovery, planning, leaving a written note, final acts such as sorting out finances, and using a violent method. On the other hand, there are protective factors that can reduce the risk of suicide, such as family support, having children at home, and religious belief. It is important to consider both risk and protective factors when assessing suicide risk and developing a treatment plan.

Discontinuation syndrome, characterized by dizziness, electric shock sensations, and anxiety, is a common occurrence when SSRIs are abruptly stopped. This is why it is recommended to gradually taper off the medication. The patient in this scenario stopped their medication abruptly due to a suspected neurological event, leading to the onset of discontinuation syndrome. Atorvastatin, bisoprolol, and gabapentin are not typically associated with these symptoms when stopped abruptly.

Selective serotonin reuptake inhibitors (SSRIs) are commonly used as the first-line treatment for depression. Citalopram and fluoxetine are the preferred SSRIs, while sertraline is recommended for patients who have had a myocardial infarction. However, caution should be exercised when prescribing SSRIs to children and adolescents. Gastrointestinal symptoms are the most common side-effect, and patients taking SSRIs are at an increased risk of gastrointestinal bleeding. Patients should also be aware of the possibility of increased anxiety and agitation after starting a SSRI. Fluoxetine and paroxetine have a higher propensity for drug interactions.

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a warning regarding the use of citalopram due to its association with dose-dependent QT interval prolongation. As a result, citalopram and escitalopram should not be used in patients with congenital long QT syndrome, known pre-existing QT interval prolongation, or in combination with other medicines that prolong the QT interval. The maximum daily dose of citalopram is now 40 mg for adults, 20 mg for patients older than 65 years, and 20 mg for those with hepatic impairment.

When initiating antidepressant therapy, patients should be reviewed by a doctor after 2 weeks. Patients under the age of 25 years or at an increased risk of suicide should be reviewed after 1 week. If a patient responds well to antidepressant therapy, they should continue treatment for at least 6 months after remission to reduce the risk of relapse. When stopping a SSRI, the dose should be gradually reduced over a 4 week period, except for fluoxetine. Paroxetine has a higher incidence of discontinuation symptoms, including mood changes, restlessness, difficulty sleeping, unsteadiness, sweating, gastrointestinal symptoms, and paraesthesia.

When considering the use of SSRIs during pregnancy, the benefits and risks should be weighed. Use during the first trimester may increase the risk of congenital heart defects, while use during the third trimester can result in persistent pulmonary hypertension of the newborn. Paroxetine has an increased risk of congenital malformations, particularly in the first trimester.

When it comes to quickly calming down patients who are exhibiting disruptive behavior, oral lorazepam is typically the first choice. According to NICE guidelines, either intramuscular lorazepam or a combination of intramuscular haloperidol and intramuscular promethazine should be used for rapid tranquilization in patients with acute behavioral disturbances. However, lorazepam is recommended for patients who have not previously taken antipsychotic medication and for those whose heart health is uncertain.

Understanding Psychosis

Psychosis is a term used to describe a person’s experience of perceiving things differently from those around them. This can manifest in various ways, including hallucinations, delusions, thought disorganization, alogia, tangentiality, clanging, and word salad. Associated features may include agitation/aggression, neurocognitive impairment, depression, and thoughts of self-harm. Psychotic symptoms can occur in a range of conditions, such as schizophrenia, depression, bipolar disorder, puerperal psychosis, brief psychotic disorder, neurological conditions, and drug use. The peak age of first-episode psychosis is around 15-30 years.

Understanding Alcohol Dependence: Symptoms and Screening Tools

Alcohol dependence is a serious condition characterized by a strong compulsion to drink, withdrawal symptoms, tolerance, and loss of control over alcohol use. This vignette illustrates a classic scenario of alcohol dependence, with features of tolerance, withdrawals, neglect of other pleasures, and low mood associated with heavy chronic alcohol consumption. While depression can be a symptom of alcohol dependence, it is not the primary diagnosis.

The term alcohol abuse is being replaced by alcohol-use disorder or harmful drinking to describe patterns of alcohol use that cause physical or mental health damage. In this vignette, the woman likely has harmful use of alcohol, but the overall picture points to a diagnosis of alcohol dependence.

Withdrawal symptoms are a common feature of alcohol dependence, and the woman in this vignette would likely experience them if she suddenly stopped drinking. Social withdrawal is also an indicator of alcohol dependence, but it does not explain the entire pattern of symptoms and behavior presented.

A useful screening test for alcohol-use disorders is the CAGE questionnaire, which asks about cutting down, annoyance from others, guilt, and needing a drink first thing in the morning. Answering yes to two or more questions may indicate the presence of an alcohol-use disorder. Other screening tools include the FAST and AUDIT tests, which can be administered quickly in busy medical settings.

Overall, understanding the symptoms and screening tools for alcohol dependence is crucial for early detection and intervention.

Somatisation refers to the manifestation of physical symptoms that cannot be explained by any underlying medical condition. On the other hand, hypochondria is a condition where a person constantly worries about having a serious illness, often believing that minor symptoms are signs of a life-threatening disease such as cancer.

Psychiatric Terms for Unexplained Symptoms

There are various psychiatric terms used to describe patients who exhibit symptoms for which no organic cause can be found. One such disorder is somatisation disorder, which involves the presence of multiple physical symptoms for at least two years, and the patient’s refusal to accept reassurance or negative test results. Another disorder is illness anxiety disorder, which is characterized by a persistent belief in the presence of an underlying serious disease, such as cancer, despite negative test results.

Conversion disorder is another condition that involves the loss of motor or sensory function, and the patient does not consciously feign the symptoms or seek material gain. Patients with this disorder may be indifferent to their apparent disorder, a phenomenon known as la belle indifference. Dissociative disorder, on the other hand, involves the process of ‘separating off’ certain memories from normal consciousness, and may manifest as amnesia, fugue, or stupor. Dissociative identity disorder (DID) is the most severe form of dissociative disorder and was previously known as multiple personality disorder.

Factitious disorder, also known as Munchausen’s syndrome, involves the intentional production of physical or psychological symptoms. Finally, malingering is the fraudulent simulation or exaggeration of symptoms with the intention of financial or other gain. Understanding these psychiatric terms can help healthcare professionals better diagnose and treat patients with unexplained symptoms.

The patient’s lengthy response to the question suggests circumstantiality, which can be a symptom of anxiety disorders or hypomania. However, the patient has remained on topic and has not derailed. Their response is coherent, and there is no evidence of pressured speech in this text-based interaction. Incoherence would be demonstrated by nonsensical statements, which is not the case here.

Anxiety is a common disorder that can manifest in various ways. According to NICE, the primary feature is excessive worry about multiple events associated with heightened tension. It is crucial to consider potential physical causes when diagnosing anxiety disorders, such as hyperthyroidism, cardiac disease, and medication-induced anxiety. Medications that may trigger anxiety include salbutamol, theophylline, corticosteroids, antidepressants, and caffeine.

NICE recommends a step-wise approach for managing generalised anxiety disorder (GAD). This includes education about GAD and active monitoring, low-intensity psychological interventions, high-intensity psychological interventions or drug treatment, and highly specialist input. Sertraline is the first-line SSRI for drug treatment, and if it is ineffective, an alternative SSRI or a serotonin-noradrenaline reuptake inhibitor (SNRI) such as duloxetine or venlafaxine may be offered. If the patient cannot tolerate SSRIs or SNRIs, pregabalin may be considered. For patients under 30 years old, NICE recommends warning them of the increased risk of suicidal thinking and self-harm and weekly follow-up for the first month.

The management of panic disorder also follows a stepwise approach, including recognition and diagnosis, treatment in primary care, review and consideration of alternative treatments, review and referral to specialist mental health services, and care in specialist mental health services. NICE recommends either cognitive behavioural therapy or drug treatment in primary care. SSRIs are the first-line drug treatment, and if contraindicated or no response after 12 weeks, imipramine or clomipramine should be offered.